4//SEC Filing
CAPEK JOHN M 4
Accession 0001415889-21-005966
CIK 0000001800other
Filed
Dec 14, 7:00 PM ET
Accepted
Dec 15, 6:32 PM ET
Size
9.0 KB
Accession
0001415889-21-005966
Insider Transaction Report
Form 4
CAPEK JOHN M
Executive Vice President
Transactions
- Sale
Common shares without par value
2021-12-13$135.05/sh−149,600$20,203,704→ 321,398 total - Exercise/Conversion
Common shares without par value
2021-12-13$34.94/sh+149,600$5,227,024→ 470,998 total - Exercise/Conversion
Option (right to buy)
2021-12-13−149,600→ 0 totalExercise: $34.94From: 2016-02-15Exp: 2023-02-14→ Common Shares (149,600 underlying)
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $135.00 to $135.295 inclusive. The reporting person undertakes to provide to Abbott Laboratories, any security holder of Abbott Laboratories, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote.
- [F2]Employee stock option granted pursuant to the Abbott Laboratories 2009 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.
Documents
Issuer
ABBOTT LABORATORIES
CIK 0000001800
Entity typeother
Related Parties
1- filerCIK 0001328034
Filing Metadata
- Form type
- 4
- Filed
- Dec 14, 7:00 PM ET
- Accepted
- Dec 15, 6:32 PM ET
- Size
- 9.0 KB